Dongwha Pharm.Co.Ltd (000020) — Cash Flow Reinvestment Rate
Dongwha Pharm.Co.Ltd (000020) has a Cash Flow Reinvestment Rate of 5.88x as of March 2026, reinvesting ₩4.10 Billion (capex ₩3.71 Billion plus investments ₩390.62 Million) from operating cash flow of ₩697.02 Million. Check 000020 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Dongwha Pharm.Co.Ltd Cash Flow Reinvestment Rate (2011–2025)
Historical reinvestment intensity for Dongwha Pharm.Co.Ltd across 12 annual periods. Explore 000020 long-term investments to assets to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Dongwha Pharm.Co.Ltd (2011–2025)
Year-by-year capital reinvestment analysis for Dongwha Pharm.Co.Ltd. For live market cap and broader valuation context, see Dongwha Pharm.Co.Ltd (000020) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 3.81x | ₩59.79 Billion | ₩15.70 Billion | ₩55.30 Billion | ▲ +280.3% |
| 2023 | 1.00x | ₩29.21 Billion | ₩29.17 Billion | ₩26.35 Billion | ▼ -37.7% |
| 2022 | 1.61x | ₩47.00 Billion | ₩29.22 Billion | ₩18.43 Billion | ▲ +144.1% |
| 2021 | 0.66x | ₩23.74 Billion | ₩36.03 Billion | ₩21.94 Billion | ▼ -29.9% |
| 2020 | 0.94x | ₩49.13 Billion | ₩52.23 Billion | ₩34.25 Billion | ▲ +20.0% |
| 2019 | 0.78x | ₩10.42 Billion | ₩13.28 Billion | ₩4.80 Billion | ▼ -39.3% |
| 2016 | 1.29x | ₩32.93 Billion | ₩25.48 Billion | ₩2.50 Billion | ▲ +2332.7% |
| 2015 | 0.05x | ₩1.05 Billion | ₩19.83 Billion | ₩885.50 Million | ▼ -83.2% |
| 2014 | 0.32x | ₩4.28 Billion | ₩13.51 Billion | ₩1.28 Billion | ▼ -84.0% |
| 2013 | 1.98x | ₩16.24 Billion | ₩8.21 Billion | ₩3.24 Billion | ▲ +142.7% |
| 2012 | 0.82x | ₩20.58 Billion | ₩25.23 Billion | ₩6.48 Billion | ▲ +305.1% |
| 2011 | 0.20x | ₩9.31 Billion | ₩46.24 Billion | ₩9.15 Billion | — |